Modular Medical Financials

MODD Stock

USD 0.49 0.01 2.08%

Modular Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February. At present, Modular Medical's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.5 M, whereas Net Debt is projected to grow to (10.5 M).

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Modular Medical Balance Sheet Chart

At present, Modular Medical's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 1.5 M, whereas Net Debt is projected to grow to (10.5 M).

Common Stock Shares Outstanding Other Current Liab Total Current Liabilities Other Stockholder Equity

Key indicators impacting Modular Medical's financial strength include:

Current Value

Last Year

Change From Last Year

10 Year Trend

Current Ratio

11.67

12.29

Notably Down

Very volatile

The financial analysis of Modular Medical is a critical element in measuring its lifeblood. Investors should not minimize Modular Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(16.09 Million)

Build AI portfolio with Modular Stock

Please note, the presentation of Modular Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Modular Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Modular Medical's management manipulating its earnings.

Modular Medical Stock Summary

Modular Medical competes with Vicarious Surgical, Nexalin Technology, IBio Common, Hyperion DeFi, and Iterum Therapeutics. Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. Modular Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 25 people.

Specialization	Health Care, Health Care Equipment & Services
Instrument	USA Stock View All
Exchange	NASDAQ Exchange
ISIN	US60785L2079
Business Address	10740 Thornmint Road,
Sector	Health Care Equipment & Supplies
Industry	Health Care
Benchmark	Dow Jones Industrial
Website	www.modularmedical.com
Phone	858 800 3500
Currency	USD - US Dollar

Modular Medical Key Financial Ratios

	Return On Equity	-3.09
	EBITDA	(17.39 M)
	Net Income	(18.82 M)
	Cash Per Share	1.25 X
	Debt To Equity	0.01 %

More Fundamentals

Modular Medical Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Retained Earnings	(34.6M)	(48.5M)	(65.9M)	(84.8M)	(76.3M)	(72.5M)
Other Current Liab	524.9K	339K	280K	504K	579.6K	608.6K
Total Liab	1.0M	2.2M	2.3M	1.7M	1.9M	2.0M
Total Assets	9.8M	7.2M	13.8M	18.7M	21.5M	22.6M
Net Debt	(8.9M)	(2.3M)	(8.0M)	(12.3M)	(11.1M)	(10.5M)
Accounts Payable	300.0K	285K	802K	338K	388.7K	408.1K
Cash	9.1M	3.8M	9.2M	13.1M	15.1M	15.8M
Total Current Assets	9.4M	4.0M	9.7M	13.5M	15.5M	16.3M
Common Stock	10.5K	10.9K	32K	54K	62.1K	65.2K
Other Current Assets	313.4K	146.9K	318K	352K	404.8K	425.0K
Net Tangible Assets	2.9M	(1.3M)	8.8M	5.1M	5.8M	4.3M
Net Invested Capital	8.8M	5.1M	11.5M	17.1M	19.6M	20.6M
Net Working Capital	8.4M	3.1M	8.2M	12.3M	14.1M	14.8M
Capital Stock	10.5K	10.9K	32K	54K	62.1K	65.2K
Short Term Debt	144.9K	355K	373K	423K	380.7K	535.4K

Modular Medical Key Income Statement Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Operating Income	(14.9M)	(13.9M)	(17.5M)	(19.0M)	(17.1M)	(16.3M)
Ebit	(15.9M)	(13.9M)	(17.5M)	(18.8M)	(16.9M)	(16.1M)
Ebitda	(15.7M)	(13.5M)	(16.7M)	(17.4M)	(15.7M)	(14.9M)
Income Before Tax	(18.6M)	(13.9M)	(17.5M)	(18.8M)	(16.9M)	(16.1M)
Net Income	(18.6M)	(13.9M)	(17.5M)	(18.8M)	(16.9M)	(16.1M)
Interest Expense	28.7K	39.8K	2.8M	975K	1.1M	1.2M
Net Interest Income	28.7K	(39.7K)	(2.8M)	(547.3K)	(492.6K)	(517.2K)
Gross Profit	(196.9K)	(355.4K)	(768K)	(1.4M)	(1.3M)	(1.2M)
Research Development	7.7M	9.1M	12.9M	14.7M	16.9M	17.7M
Cost Of Revenue	196.9K	355.4K	768K	1.4M	1.6M	1.7M

Modular Medical Key Cash Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Change In Cash	7.6M	(5.3M)	5.4M	3.9M	4.4M	4.7M
Free Cash Flow	(10.3M)	(12.6M)	(15.7M)	(18.2M)	(16.4M)	(15.6M)
Other Non Cash Items	3.8M	202.7K	143K	52K	59.8K	56.8K
Capital Expenditures	54.8K	1.6M	1.7M	2.5M	2.9M	3.0M
Net Income	(18.6M)	(13.9M)	(17.5M)	(18.8M)	(16.9M)	(16.1M)
End Period Cash Flow	9.1M	3.8M	9.2M	13.1M	15.1M	15.8M
Investments	(54.8K)	(1.6M)	(1.7M)	(2.5M)	(2.2M)	(2.1M)
Depreciation	117.5K	152.4K	768K	1.1M	1.2M	1.3M
Change To Netincome	801.2K	1.3M	5.3M	2.7M	3.1M	1.9M

Modular Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Modular Medical's current stock value. Our valuation model uses many indicators to compare Modular Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Modular Medical competition to find correlations between indicators driving Modular Medical's intrinsic value. More Info.

Modular Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Modular Medical's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Modular Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Most indicators from Modular Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Modular Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Modular Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Modular Stock refer to our How to Trade Modular Stock guide.At present, Modular Medical's Enterprise Value is projected to increase significantly based on the last few years of reporting.

	2023	2024	2025	2026 (projected)
Cost Of Revenue	768K	1.4M	1.6M	1.7M
Research Development	12.9M	14.7M	16.9M	17.7M

Cost Of Revenue Research Development

Modular Medical fundamental ratios Correlations

	Common Stock Shares Outstanding	Retained Earnings	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Stockholder Equity	Total Liab	Total Assets	Net Debt	Accounts Payable	Cash	Cash And Short Term Investments	Total Current Assets	Common Stock	Property Plant And Equipment Net	Non Current Assets Total	Inventory	Short Long Term Debt Total	Current Deferred Revenue	Other Current Assets	Net Tangible Assets	Net Invested Capital	Net Working Capital	Intangible Assets	Property Plant Equipment	Good Will
Common Stock Shares Outstanding		-0.93	0.76	0.51	0.96	0.98	0.58	0.54	-0.41	0.45	0.5	0.48	0.51	0.98	0.65	0.65	0.32	0.34	-0.58	0.9	0.47	0.97	0.91	-0.79	0.91	0.75
Retained Earnings	-0.93		-0.82	-0.58	-0.91	-0.98	-0.69	-0.55	0.41	-0.52	-0.51	-0.49	-0.52	-0.88	-0.66	-0.66	-0.29	-0.45	0.7	-0.94	-0.57	-0.92	-0.86	0.8	-0.96	-0.57
Other Current Liab	0.76	-0.82		0.79	0.71	0.82	0.8	0.47	-0.35	0.36	0.45	0.43	0.45	0.69	0.55	0.55	0.39	0.6	-0.71	0.91	0.39	0.75	0.66	-0.82	0.73	0.57
Total Current Liabilities	0.51	-0.58	0.79		0.39	0.54	0.96	0.42	-0.25	0.39	0.4	0.38	0.41	0.45	0.48	0.48	0.27	0.92	-0.7	0.68	0.03	0.43	0.28	-0.7	0.53	0.3
Total Stockholder Equity	0.96	-0.91	0.71	0.39		0.96	0.47	0.57	-0.45	0.48	0.54	0.52	0.55	0.97	0.66	0.66	0.32	0.19	-0.62	0.9	0.69	1.0	0.99	-0.8	0.86	0.7
Other Stockholder Equity	0.98	-0.98	0.82	0.54	0.96		0.64	0.55	-0.41	0.49	0.51	0.49	0.52	0.94	0.66	0.66	0.31	0.38	-0.65	0.95	0.57	0.97	0.91	-0.82	0.95	0.69
Total Liab	0.58	-0.69	0.8	0.96	0.47	0.64		0.47	-0.29	0.47	0.44	0.42	0.45	0.51	0.55	0.56	0.28	0.93	-0.77	0.73	0.14	0.5	0.35	-0.77	0.69	0.32
Total Assets	0.54	-0.55	0.47	0.42	0.57	0.55	0.47		-0.64	0.19	1.0	1.0	1.0	0.56	0.98	0.98	0.01	0.33	-0.59	0.57	0.48	0.55	0.53	-0.62	0.51	0.31
Net Debt	-0.41	0.41	-0.35	-0.25	-0.45	-0.41	-0.29	-0.64		-0.15	-0.64	-0.64	-0.64	-0.43	-0.64	-0.64	-0.05	-0.16	0.42	-0.43	-0.41	-0.43	-0.44	0.43	-0.37	-0.23
Accounts Payable	0.45	-0.52	0.36	0.39	0.48	0.49	0.47	0.19	-0.15		0.17	0.14	0.18	0.46	0.25	0.25	0.08	0.32	-0.57	0.53	0.4	0.46	0.44	-0.55	0.5	0.22
Cash	0.5	-0.51	0.45	0.4	0.54	0.51	0.44	1.0	-0.64	0.17		1.0	1.0	0.52	0.97	0.97	0.0	0.31	-0.58	0.54	0.47	0.52	0.5	-0.59	0.47	0.29
Cash And Short Term Investments	0.48	-0.49	0.43	0.38	0.52	0.49	0.42	1.0	-0.64	0.14	1.0		1.0	0.5	0.97	0.97	0.01	0.29	-0.55	0.52	0.46	0.5	0.48	-0.57	0.45	0.28
Total Current Assets	0.51	-0.52	0.45	0.41	0.55	0.52	0.45	1.0	-0.64	0.18	1.0	1.0		0.53	0.97	0.97	0.01	0.31	-0.58	0.55	0.48	0.52	0.51	-0.6	0.48	0.29
Common Stock	0.98	-0.88	0.69	0.45	0.97	0.94	0.51	0.56	-0.43	0.46	0.52	0.5	0.53		0.66	0.66	0.31	0.25	-0.59	0.86	0.52	0.97	0.93	-0.79	0.86	0.74
Property Plant And Equipment Net	0.65	-0.66	0.55	0.48	0.66	0.66	0.55	0.98	-0.64	0.25	0.97	0.97	0.97	0.66		1.0	0.05	0.39	-0.63	0.66	0.47	0.64	0.6	-0.68	0.65	0.4
Non Current Assets Total	0.65	-0.66	0.55	0.48	0.66	0.66	0.56	0.98	-0.64	0.25	0.97	0.97	0.97	0.66	1.0		0.05	0.4	-0.63	0.66	0.47	0.64	0.6	-0.68	0.65	0.4
Inventory	0.32	-0.29	0.39	0.27	0.32	0.31	0.28	0.01	-0.05	0.08	0.0	0.01	0.01	0.31	0.05	0.05		0.18	-0.31	0.32	0.24	0.32	0.3	-0.35	0.29	0.27
Short Long Term Debt Total	0.34	-0.45	0.6	0.92	0.19	0.38	0.93	0.33	-0.16	0.32	0.31	0.29	0.31	0.25	0.39	0.4	0.18		-0.62	0.47	-0.09	0.23	0.06	-0.56	0.48	0.15
Current Deferred Revenue	-0.58	0.7	-0.71	-0.7	-0.62	-0.65	-0.77	-0.59	0.42	-0.57	-0.58	-0.55	-0.58	-0.59	-0.63	-0.63	-0.31	-0.62		-0.72	-0.59	-0.61	-0.56	0.92	-0.64	-0.26
Other Current Assets	0.9	-0.94	0.91	0.68	0.9	0.95	0.73	0.57	-0.43	0.53	0.54	0.52	0.55	0.86	0.66	0.66	0.32	0.47	-0.72		0.57	0.91	0.86	-0.85	0.85	0.62
Net Tangible Assets	0.47	-0.57	0.39	0.03	0.69	0.57	0.14	0.48	-0.41	0.4	0.47	0.46	0.48	0.52	0.47	0.47	0.24	-0.09	-0.59	0.57		0.64	0.74	-0.58	0.47	0.28
Net Invested Capital	0.97	-0.92	0.75	0.43	1.0	0.97	0.5	0.55	-0.43	0.46	0.52	0.5	0.52	0.97	0.64	0.64	0.32	0.23	-0.61	0.91	0.64		0.98	-0.8	0.86	0.72
Net Working Capital	0.91	-0.86	0.66	0.28	0.99	0.91	0.35	0.53	-0.44	0.44	0.5	0.48	0.51	0.93	0.6	0.6	0.3	0.06	-0.56	0.86	0.74	0.98		-0.74	0.78	0.68
Intangible Assets	-0.79	0.8	-0.82	-0.7	-0.8	-0.82	-0.77	-0.62	0.43	-0.55	-0.59	-0.57	-0.6	-0.79	-0.68	-0.68	-0.35	-0.56	0.92	-0.85	-0.58	-0.8	-0.74		-0.78	-0.58
Property Plant Equipment	0.91	-0.96	0.73	0.53	0.86	0.95	0.69	0.51	-0.37	0.5	0.47	0.45	0.48	0.86	0.65	0.65	0.29	0.48	-0.64	0.85	0.47	0.86	0.78	-0.78		0.61
Good Will	0.75	-0.57	0.57	0.3	0.7	0.69	0.32	0.31	-0.23	0.22	0.29	0.28	0.29	0.74	0.4	0.4	0.27	0.15	-0.26	0.62	0.28	0.72	0.68	-0.58	0.61

Click cells to compare fundamentals

Modular Medical Account Relationship Matchups

Modular Medical fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Retained Earnings	(34.6M)	(48.5M)	(65.9M)	(84.8M)	(76.3M)	(72.5M)
Other Current Liab	524.9K	339K	280K	504K	579.6K	608.6K
Total Liab	1.0M	2.2M	2.3M	1.7M	1.9M	2.0M
Total Assets	9.8M	7.2M	13.8M	18.7M	21.5M	22.6M
Net Debt	(8.9M)	(2.3M)	(8.0M)	(12.3M)	(11.1M)	(10.5M)
Accounts Payable	300.0K	285K	802K	338K	388.7K	408.1K
Cash	9.1M	3.8M	9.2M	13.1M	15.1M	15.8M
Total Current Assets	9.4M	4.0M	9.7M	13.5M	15.5M	16.3M
Common Stock	10.5K	10.9K	32K	54K	62.1K	65.2K
Other Current Assets	313.4K	146.9K	318K	352K	404.8K	425.0K
Net Tangible Assets	2.9M	(1.3M)	8.8M	5.1M	5.8M	4.3M
Net Invested Capital	8.8M	5.1M	11.5M	17.1M	19.6M	20.6M
Net Working Capital	8.4M	3.1M	8.2M	12.3M	14.1M	14.8M
Capital Stock	10.5K	10.9K	32K	54K	62.1K	65.2K
Short Term Debt	144.9K	355K	373K	423K	380.7K	535.4K

Today, most investors in Modular Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Modular Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Modular Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0585

At present, Modular Medical's Price Earnings To Growth Ratio is projected to increase significantly based on the last few years of reporting.

Modular Medical January 10, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Modular Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Modular Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Modular Medical based on widely used predictive technical indicators. In general, we focus on analyzing Modular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Modular Medical's daily price indicators and compare them against related drivers.

	Information Ratio	(0.04)
	Maximum Drawdown	45.4
	Value At Risk	(8.11)
	Potential Upside	10.42

Complementary Tools for Modular Stock analysis

When running Modular Medical's price analysis, check to measure Modular Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Modular Medical is operating at the current time. Most of Modular Medical's value examination focuses on studying past and present price action to predict the probability of Modular Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Modular Medical's price. Additionally, you may evaluate how the addition of Modular Medical to your portfolios can decrease your overall portfolio volatility.

	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Modular Medical Financials

Modular Medical Balance Sheet Chart

Net Income

(16.09 Million)

Modular Medical Stock Summary

Modular Medical Key Financial Ratios

Modular Medical Key Balance Sheet Accounts

Modular Medical Key Income Statement Accounts

Modular Medical Key Cash Accounts

Modular Financial Ratios Relationships

Modular Medical fundamental ratios Correlations

Modular Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Modular Medical fundamental ratios Accounts

Price Earnings To Growth Ratio

0.0585

Modular Medical January 10, 2026 Opportunity Range

Complementary Tools for Modular Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Stockholder Equity
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Other Stockholder Equity	- 0.98	Retained Earnings
Property Plant Equipment	- 0.96	Retained Earnings
Other Current Assets	- 0.94	Retained Earnings
Retained Earnings	- 0.93	Common Stock Shares Outstanding
Net Invested Capital	- 0.92	Retained Earnings
Total Stockholder Equity	- 0.91	Retained Earnings